<DOC>
	<DOCNO>NCT01710033</DOCNO>
	<brief_summary>This Phase 1 dose escalation study evaluate safety , tolerability pharmacokinetics 28-day treatment CP-690,550 stable renal allograft recipient . In Stage 1 , ascend dos CP-690,550 administer sequentially 3-4 cohort subject . After Stage 1 , one dose level select dose expand cohort Stage 2 .</brief_summary>
	<brief_title>A Study Of CP-690,550 In Stable Kidney Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Medically stable kidney transplant patient 6 month transplantation . Subjects must mycophenolate mofetil 12 gm daily In Cohort 3 ( 4 , conduct ) Stage 1 expand cohort Stage 2 , subject must calcineurin inhibitorfree regimen . Any rejection episodes precede 3 month . Treated Thymoglobulin OKT3 acute rejection past 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>CP-690,550</keyword>
	<keyword>kidney transplant</keyword>
</DOC>